Rivian Automotive, Inc.

RIVN · NASDAQ

Low target$10.00
Average target$19.10
High target$25.00

Analyst ratings

buy · 20 ratings

DateFirmActionRatingPrice target
July 14, 2026Morgan StanleyMaintainsUnderweight$13.00
July 9, 2026UBSMaintainsNeutral$17.00
July 8, 2026BNP ParibasMaintainsOutperform$24.00
July 7, 2026JefferiesMaintainsHold$17.00
June 10, 2026NeedhamReiteratesBuy$23.00
June 3, 2026TD CowenReiteratesBuy$20.00
May 11, 2026DA DavidsonMaintainsNeutral$15.00
May 1, 2026BNP ParibasReiteratesOutperform$22.00
May 1, 2026Cantor FitzgeraldMaintainsNeutral$19.00
May 1, 2026BenchmarkReiteratesBuy$25.00
May 1, 2026NeedhamReiteratesBuy$23.00
April 10, 2026Tigress FinancialMaintainsBuy$25.00
April 6, 2026Canaccord GenuityMaintainsBuy$22.00
April 1, 2026DA DavidsonUpgradesNeutral$14.00
March 20, 2026Canaccord GenuityMaintainsBuy$22.00
March 10, 2026TD CowenUpgradesBuy$20.00
February 17, 2026StifelMaintainsBuy$20.00
February 17, 2026DA DavidsonDowngradesUnderperform$14.00
February 13, 2026UBSUpgradesNeutral$16.00
February 13, 2026TD CowenMaintainsHold$17.00
February 13, 2026WedbushReiteratesOutperform$25.00
February 13, 2026Piper SandlerMaintainsNeutral$18.00
February 13, 2026Wells FargoMaintainsEqual-Weight$15.00
February 13, 2026BenchmarkMaintainsBuy$25.00
February 13, 2026Deutsche BankUpgradesBuy$23.00
January 14, 2026UBSDowngradesSell$15.00
January 8, 2026Piper SandlerMaintainsNeutral$20.00
December 19, 2025WedbushMaintainsOutperform$25.00
December 18, 2025BairdUpgradesOutperform$25.00
December 12, 2025Goldman SachsMaintainsNeutral$16.00
December 12, 2025NeedhamMaintainsBuy$23.00
December 8, 2025Morgan StanleyDowngradesUnderweight$12.00
November 17, 2025StifelMaintainsBuy$17.00
November 14, 2025Tigress FinancialMaintainsBuy$25.00
November 11, 2025DA DavidsonMaintainsNeutral$15.00
November 5, 2025Goldman SachsMaintainsNeutral$13.00
October 20, 2025JP MorganMaintainsUnderweight$10.00
October 20, 2025MizuhoDowngradesUnderperform$10.00
October 6, 2025UBSMaintainsNeutral$13.00
October 3, 2025Canaccord GenuityMaintainsBuy$21.00
September 29, 2025Goldman SachsMaintainsNeutral$15.00
September 23, 2025MizuhoMaintainsNeutral$14.00
August 25, 2025NeedhamReiteratesBuy$14.00

R2 SUV launch and path to profitability

Bull case

The R2 midsize SUV is viewed as a transformational catalyst capable of driving Rivian toward profitability by the end of the decade. Q2 2026 delivery beats and raised full-year guidance to 65,000–70,000 vehicles signal growing operational momentum, with the most optimistic analysts setting price targets as high as $25.

Bear case

Rivian has already abandoned its 2027 profitability target, pushing positive EBITDA expectations to 2028 at the earliest. Negative automotive gross margins persisted into Q1 2026 at -$62 million, and management's own guidance projects adjusted EBITDA of -$1.8B to -$2.1B for full-year 2026, raising serious doubts about execution timelines.

Equity dilution and capital raise strategy

Bull case

The $1.5B capital raise, while dilutive, strengthened Rivian's cash position to $5.3 billion and fulfills mandatory DOE loan equity contributions. This liquidity runway, supplemented by a $1 billion Volkswagen investment, provides the financial foundation needed to execute the R2 ramp-up and Georgia plant construction.

Bear case

Rivian's $1.74B stock offering — timed immediately after a 19% rally — directly dilutes existing shareholders and triggered a 15% single-day share price collapse. With short interest at 13.26% and ongoing cash burn, repeated equity issuances raise structural concerns about the company's ability to self-fund operations.

Analyst conviction and valuation credibility

Bull case

Following the Q2 delivery beat, analysts at Morgan Stanley, UBS, and BNP Paribas all raised their price targets, with BNP Paribas maintaining an Outperform rating and a $24 target. The stock carries a Buy consensus rating with an average price target of $20.47, reflecting confidence in Rivian's multi-year growth trajectory.

Bear case

Analyst opinion on Rivian is deeply fractured, with price targets ranging from $9 to $25 and only 11 of 26 covering analysts rating it Buy or higher, while 5 rate it Sell or Strong Sell. Morgan Stanley maintains an Underweight rating with a $13 target, underscoring massive uncertainty around the company's production and financial timeline.